What the Aging Field Needs — Celine Halioua

celinehh.com · 1,697 words · saved by 3 readers

The basic thesis behind the aging field is that we can increase healthspan (quality of life) and lifespan (number of years lived) by developing medicines which specifically treat the ways our bodies age over time. The ability of certain drugs to increase lifespan & healthspan has been demonstrated hundreds of times in model organisms like mice, but to date no drug has ever been approved to explicitly treat aging in humans. Aging drugs, if they live up to the fields’ dreams, could significantly improve quality of life and reduce disease burden and misery for millions of people. The reasons we do not have an approved aging drug today are not due to the science - the biological blockers to a first-generation aging drug have been clear for at least ten years. The primary reasons there are no approved aging drugs today are much more tricky - they are regulatory, societal, structural, and cultural.[a] For the last years, I’ve been a researcher in academic aging labs, worked in aging-focused

What the Aging Field Needs - Celine Halioua Celine Halioua What the aging field needs May 4, 2021 The first aging drug could be approved this decade. The basic thesis behind the aging field is that we can increase healthspan (quality of life) and lifespan (number of years lived) by developing medicines which specifically treat the ways our bodies age over time. The ability of certain drugs to increase lifespan & healthspan has been demonstrated hundreds of times in model organisms like mice, but to date no drug has ever been approved to explicitly treat aging in humans. Aging drugs, if they li

What the Aging Field Needs — Celine Halioua

saved by

related reading